| Identification | Back Directory |  [Name]
  (3S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic  acid |  [CAS]
  291775-59-2 |  [Synonyms]
  LED-C-3 Ledipasvir INT 2 Ledipasvir Impurity 14 (3S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic  acid (1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid (1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid 97% (3S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic  acid ISO 9001:2015 REACH (1R,3S,4S)-2-Azabicyclo[2.2.1]heptane-2,3-dicarboxylic acid 2-tert-butyl ester (1R,3S,4S)-N-(Tert-butoxycarbonyl)-2-azabicyclo-[2.2.1]-heptane-3-carboxylic acid (1R,3S,4S)-3-[(2-methylpropoxy)carbonyl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 2-Azabicyclo[2.2.1]heptane-2,3-dicarboxylic acid, 2-(1,1-diMethylethyl) ester, (1R,3S,4S)- |  [EINECS(EC#)]
  808-164-2 |  [Molecular Formula]
  C12H19NO4 |  [MDL Number]
  MFCD11099876 |  [MOL File]
  291775-59-2.mol |  [Molecular Weight]
  241.28 |  
 | Chemical Properties | Back Directory |  [Melting point ]
  147-152 °C |  [Boiling point ]
  371.0±25.0 °C(Predicted) |  [density ]
  1.232±0.06 g/cm3(Predicted) |  [storage temp. ]
  Sealed in dry,Room Temperature |  [form ]
  powder |  [pka]
  4.05±0.20(Predicted) |  [Optical Rotation]
  [α]22/D -170±10°, c = 1 in chloroform |  [InChI]
  InChI=1S/C12H19NO4/c1-12(2,3)17-11(16)13-8-5-4-7(6-8)9(13)10(14)15/h7-9H,4-6H2,1-3H3,(H,14,15)/t7-,8+,9-/m0/s1 |  [InChIKey]
  IFAMSTPTNRJBRG-YIZRAAEISA-N |  [SMILES]
  [C@]12([H])C[C@]([H])(CC1)[C@@H](C(O)=O)N2C(OC(C)(C)C)=O |  
 | Hazard Information | Back Directory |  [Uses]
  (1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic Acid is a building block in the synthesis of Ledipasvir, a potent, once-??daily oral NS5A inhibitor for the treatment of Hepatitis C Virus infection. It is also used to prepare potent direct inhibitors of factor Xa which carries significant promise for developing effective and safe anticoagulants. |  
  
             | 
            
            
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
             |